The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance

V. Crudu, E. Romancenco, E. Noroc, N. Turcan, G. Blagodeteleva (Chisinau, Republic Of Moldova)

Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Session: Diagnostic features of tuberculosis I
Session type: Thematic Poster Session
Number: 2779
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Crudu, E. Romancenco, E. Noroc, N. Turcan, G. Blagodeteleva (Chisinau, Republic Of Moldova). The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance. Eur Respir J 2013; 42: Suppl. 57, 2779

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


MDR-TB treatment outcomes in HIV positive patients
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Risk factors for acquired drug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014

Risk factor and resistance pattern of MDR TB among suspected cases of Oromia Region
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013

Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015